Sign in

CIK 0001778922

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

SpyGlass Pharma, Inc.

Sign in to watch
Ticker
SGP
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833044245
Phone
+1 949-284-6904
Business address
15326 ALTON PARKWAY, IRVINE, CA, 92618
Former names
SpyGlassPharma, Inc., SpyGlass Ophthalmics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-05 Scheiner Zachary Director Grant or award · Stock Option (right to buy) +27,400 27,400
2026-02-05 Pardo Geoffrey B Director Grant or award · Stock Option (right to buy) +27,400 27,400
2026-02-05 O'Farrell Elizabeth G. Director Grant or award · Stock Option (right to buy) +13,700 13,700
2026-02-05 Dable Habib J Director Grant or award · Stock Option (right to buy) +27,400 27,400
2026-02-05 Dybbs Michael Director Grant or award · Stock Option (right to buy) +27,400 27,400
2026-02-05 Nielsen Kirk G. Director Grant or award · Stock Option (right to buy) +27,400 27,400
2026-02-05 Viret Jean-Frederic Chief Financial Officer Grant or award · Stock Option (right to buy) +17,500 17,500
2026-02-05 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (right to buy) +27,400 27,400
2026-02-05 Behbahani Ali Director Grant or award · Stock Option (right to buy) +27,400 27,400

Page 9 of 9 · 169 trades